Article
Combination epigenetic-targeted therapy increases the immunogenicity of poorly immunogenic sarcomas
2026-06-21
Abstract excerpt
Immunotherapy approaches have shown limited efficacy in pediatric sarcomas, partly because these tumors have low mutation burden and few neoantigens. We sought to increase the immunogenicity of low mutation sarcomas by inducing expression of epigenetically silenced genes using the hypomethylating agent decitabine and histone deacetylase inhibitor entinostat. Using a mutated Kras-driven murine sarcoma model KP Sarc...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c224fb22-0c48-5be5-aa96-eaae683395f5
- DOI
- 10.64898/2026.06.18.733244
